Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| type I pneumocyte | 7 studies | 23% ± 8% | |
| CD4-positive, alpha-beta T cell | 5 studies | 20% ± 5% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 4 studies | 26% ± 8% | |
| T cell | 3 studies | 22% ± 7% |
Insufficient scRNA-seq data for expression of PGGHG at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 78190.89 | 327 / 328 | 85% | 75.73 | 151 / 178 |
| uterus | 96% | 6224.87 | 163 / 170 | 80% | 67.67 | 367 / 459 |
| lung | 100% | 18422.95 | 578 / 578 | 74% | 61.71 | 860 / 1155 |
| kidney | 99% | 13185.96 | 88 / 89 | 72% | 117.94 | 647 / 901 |
| intestine | 96% | 9574.71 | 928 / 966 | 73% | 46.43 | 383 / 527 |
| breast | 100% | 11937.69 | 459 / 459 | 64% | 52.25 | 717 / 1118 |
| thymus | 100% | 19148.22 | 651 / 653 | 55% | 49.09 | 334 / 605 |
| bladder | 86% | 5972.67 | 18 / 21 | 69% | 45.70 | 346 / 504 |
| liver | 95% | 9034.49 | 214 / 226 | 55% | 35.38 | 225 / 406 |
| stomach | 84% | 3514.60 | 301 / 359 | 65% | 31.23 | 187 / 286 |
| prostate | 99% | 10210.04 | 242 / 245 | 49% | 13.52 | 248 / 502 |
| esophagus | 88% | 4245.16 | 1268 / 1445 | 54% | 23.55 | 99 / 183 |
| ovary | 48% | 1795.33 | 87 / 180 | 79% | 78.36 | 341 / 430 |
| skin | 51% | 1691.91 | 922 / 1809 | 50% | 15.53 | 235 / 472 |
| spleen | 100% | 25933.02 | 241 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 24712.71 | 924 / 929 | 0% | 0 | 0 / 0 |
| adipose | 99% | 5915.98 | 1190 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 59.47 | 27 / 29 |
| blood vessel | 91% | 5039.41 | 1210 / 1335 | 0% | 0 | 0 / 0 |
| heart | 70% | 2705.60 | 607 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 62% | 24.19 | 28 / 45 |
| brain | 8% | 214.72 | 208 / 2642 | 37% | 9.19 | 260 / 705 |
| eye | 0% | 0 | 0 / 0 | 28% | 6.73 | 22 / 80 |
| adrenal gland | 20% | 553.78 | 51 / 258 | 4% | 1.08 | 10 / 230 |
| muscle | 3% | 76.98 | 21 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005975 | Biological process | carbohydrate metabolic process |
| GO_0005829 | Cellular component | cytosol |
| GO_0047402 | Molecular function | protein-glucosylgalactosylhydroxylysine glucosidase activity |
| Gene name | PGGHG |
| Protein name | Protein-glucosylgalactosylhydroxylysine glucosidase (EC 3.2.1.107) (Acid trehalase-like protein 1) ATH1, acid trehalase-like 1 (Yeast), isoform CRA_a (Testicular tissue protein Li 25) Protein-glucosylgalactosylhydroxylysine glucosidase |
| Synonyms | ATHL1 hCG_1983956 |
| Description | FUNCTION: Catalyzes the hydrolysis of glucose from the disaccharide unit linked to hydroxylysine residues of collagen and collagen-like proteins. . |
| Accessions | ENST00000409548.7 [Q32M88-1] ENST00000397660.3 A0A024R1Z9 ENST00000409479.5 H3BM00 ENST00000482937.2 B8ZZ60 H0YCL6 Q32M88 E7EMA9 ENST00000409655.5 |
